Xilio Therapeutics, Inc. (XLO)
NASDAQ·Healthcare·Biotechnology
$7.88
-3.67%
Mkt Cap $28.36M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
-11.2%
Consensus $7.00 vs current $7.88
NASDAQ·Healthcare·Biotechnology
$7.88
-3.67%
Mkt Cap $28.36M
No recent rating data.
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
-11.2%
Consensus $7.00 vs current $7.88